Ingenia Therapeutics Inc. (KOSDAQ:950260)
South Korea · Delayed Price · Currency is KRW 25,350
-2,550 (-9.14%)
At close: Oct 8, 2026
Ingenia Therapeutics Market Cap
Ingenia Therapeutics has a market cap or net worth of 1.25 trillion as of October 8, 2026. It is the 10,612th most valuable company in the world and the 273rd biggest in South Korea.
Market Cap
1.25T
Enterprise Value
1.24T
Revenue
7.42B
Global Rank
Country Rank
#273 South Korea
PE Ratio
n/a
ChartMarket Cap Chart
Since August 18, 2026, Ingenia Therapeutics's market cap has increased from 889.51B to 1.25T, an increase of 40.91%. That is a compound annual growth rate of 1,064.10%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 8, 2026 | 1.25T | -9.14% |
| Oct 7, 2026 | 1.38T | -4.62% |
| Oct 6, 2026 | 1.45T | 1.39% |
| Oct 2, 2026 | 1.43T | -0.35% |
| Oct 1, 2026 | 1.43T | 11.35% |
| Sep 30, 2026 | 1.29T | 2.77% |
| Sep 29, 2026 | 1.25T | 3.90% |
| Sep 28, 2026 | 1.20T | -0.20% |
| Sep 23, 2026 | 1.21T | 4.05% |
| Sep 22, 2026 | 1.16T | 9.07% |
| Sep 21, 2026 | 1.06T | 16.40% |
| Sep 18, 2026 | 913.24B | 3.01% |
| Sep 17, 2026 | 886.54B | 14.28% |
| Sep 16, 2026 | 775.79B | 3.56% |
| Sep 15, 2026 | 749.09B | 6.32% |
| Sep 14, 2026 | 704.59B | -7.77% |
| Sep 11, 2026 | 763.92B | -6.42% |
| Sep 10, 2026 | 816.33B | 3.19% |
| Sep 9, 2026 | 791.11B | -0.87% |
| Sep 8, 2026 | 798.04B | -0.55% |
| Sep 7, 2026 | 802.49B | 4.17% |
| Sep 4, 2026 | 770.35B | -1.52% |
| Sep 3, 2026 | 782.21B | -8.29% |
| Sep 2, 2026 | 852.92B | -10.58% |
| Sep 1, 2026 | 953.79B | 9.35% |
| Aug 31, 2026 | 872.20B | -2.00% |
| Aug 28, 2026 | 890.00B | 3.75% |
| Aug 27, 2026 | 857.86B | 0.06% |
| Aug 26, 2026 | 857.37B | 4.71% |
| Aug 25, 2026 | 818.80B | 9.31% |
| Aug 24, 2026 | 749.09B | -3.93% |
| Aug 21, 2026 | 779.74B | -13.97% |
| Aug 20, 2026 | 906.32B | 30.00% |
| Aug 19, 2026 | 697.17B | -21.62% |
| Aug 18, 2026 | 889.51B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Penetrium Bioscience | 384.44B |
| DreamCIS | 90.41B |
| HLB bioStep | 49.46B |
| P&K Skin Research Center | 47.65B |
| Kolmar BioTech | 39.04B |
| SLS BIO | 26.89B |
| C&R Research | 26.20B |
| DT&CRO CO. | 25.22B |